Heart Disease News and Research

Latest Heart Disease News and Research

American Lung Association releases State of Tobacco Control 2009 report

The American Lung Association today released its State of Tobacco Control 2009 report, which grades the strength of federal and state laws to protect citizens from tobacco-caused illnesses.

12 Jan 2010

American Heart Association encourages more Americans to get vaccinated against H1N1

The American Heart Association supports National Influenza Vaccination Week, Jan. 10-16, an effort led by the Department of Health and Human Services and the Centers for Disease Control and Prevention (CDC) to encourage more Americans to get vaccinated against H1N1.

12 Jan 2010

Tocotrienol form of vitamin E prevents neural cell death and rescues the brain after stroke injury

Blocking the function of an enzyme in the brain with a specific kind of vitamin E can prevent nerve cells from dying after a stroke, new research suggests.

12 Jan 2010

Proteus Biomedical signs worldwide license and collaboration agreement with Novartis

Proteus Biomedical Inc., a pioneer in intelligent medicine, entered into an exclusive worldwide license and collaboration agreement with Novartis to develop and commercialize pharmaceutical products that incorporate Proteus’ novel sensor-based technologies in the field of organ transplantation.

12 Jan 2010

National Salt Reduction Initiative unveils proposed targets to reduce salt levels in packaged and restaurant foods

The National Salt Reduction Initiative, a New York City-led partnership of cities, states and national health organizations, today unveiled its proposed targets to guide a voluntary reduction of salt levels in packaged and restaurant foods.

12 Jan 2010

University Hospitals in Cleveland selects Sectra as PACS provider

University Hospitals in Cleveland, Ohio has selected the IT and medical-technology company Sectra as their PACS provider. University Hospitals has been recognized by Thomson Reuters as a Top 10 hospital system in the U.S., and by U.S. News and World Report as one of America’s best hospitals.

12 Jan 2010

U-M Congenital Heart Center invites parents to submit queries on heart defect surgeries

The public, including parents of babies with severe heart defects, are invited to submit questions for inclusion in a tweet chat about surgical approaches for heart defects from noon-2 p.m. Wednesday, Jan. 20 on Twitter.

12 Jan 2010

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

EKR Therapeutics, Inc., a specialty pharmaceutical company commercializing acute-care hospital products, today said that interim study data1 demonstrate that Cardene® I.V. (nicardipine hydrochloride) is significantly more effective than intravenous labetalol for the management of blood pressure (BP) in stroke patients.

12 Jan 2010

American Heart Association supports salt reduction initiative

The American Heart Association (AHA) applauds the efforts of New York City to work with the packaged and restaurant foods industry to reduce the amount of salt in the food supply. These efforts serve an important role in bringing both the public health community and food industry together to create solutions and help Americans live healthier lives.

12 Jan 2010

Isis Pharmaceuticals adds ISIS-APOCIIIRx to its development pipeline to treat TG

Isis Pharmaceuticals, Inc. announced today that it has added a new drug, ISIS-APOCIIIRx, to its development pipeline. ISIS-APOCIIIRx provides a novel approach to treat hypertriglyceridemia, or high levels of triglycerides (TG).

12 Jan 2010

H1N1 flu vaccines and other resources for remaining healthy to be offered at Pennsylvania Farm Show

The Department of Health is offering free H1N1 flu vaccines and other resources for remaining healthy at its exhibit at the Pennsylvania Farm Show, which runs through Jan. 16.

12 Jan 2010

Yoga lowers number of compounds in blood and reduces inflammation

Regularly practicing yoga exercises may lower a number of compounds in the blood and reduce the level of inflammation that normally rises because of both normal aging and stress, a new study has shown.

12 Jan 2010

Paragon Biomedical launches second phase of restructuring and growth plan for worldwide operations

Paragon Biomedical, Inc. announced today that it has launched the second phase of its restructuring and growth plan for worldwide operations. Gena Reed, Paragon's Founder and Chief Executive Officer, said the strategy will build upon the company's strengths in its key therapeutic areas and regions.

12 Jan 2010

Experiments show Alzheimer's drug may halt the growth of oesophageal cancer

Cancer of the gullet, or oesophagus, is one of the ten most common cancers in the Western world, and there have been recent alarming increases in the number of cases each year in the US and UK.

12 Jan 2010

Second pivotal efficacy study not required for MAP Pharmaceuticals' LEVADEX NDA

MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.

12 Jan 2010

ProPublica examines USAID efforts to fund, train local organizations in Pakistan

"As the United States prepares to drastically increase civilian aid in Pakistan, [USAID,] the agency in charge has asked for help training the local organizations that will spend that aid money, saying those organizations 'do not meet the minimum standards for managing' U.S. government funds," ProPublica reports in a story that examines the challenges associated with channeling aid money for Pakistan away from American contractors and NGOs to Pakistani organizations.

12 Jan 2010

ARCA biopharma to receive US patent for methods of heart failure treatment with genetic testing based bucindolol

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its U.S. Patent Application Number 11/226,908 entitled “Methods for Treatment with Bucindolol Based on Genetic Targeting.” The Notice of Allowance is the USPTO’s official communication that the examination of the patent application has been successfully completed and that a patent will be issued.

12 Jan 2010

PDGFR's role in new blood vessel formation may explain cardiovascular side effects

A growth factor that is a common target of cancer drugs also plays an important role in the heart's response to stress, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Journal of Clinical Investigation.

12 Jan 2010

Proteinuria, a long accepted indicator of heart disease risk, has less impact on African-Americans compared to whites

The cardiovascular risk that is associated with proteinuria, or high levels of protein in the urine, a common test used by doctors as an indicator of increased risk for progressive kidney disease, heart attack and stroke, has race-dependent effects, according to a new study by researchers at Wake Forest University School of Medicine.

12 Jan 2010

Detroit paper explores pain of facing breast cancer without insurance

A woman with a $7,000 annual income and $67 in the bank was diagnosed with breast cancer, leading to a week of phone calls from her surgeon to state, federal and hospital officials before a charitable agreement was struck with a medical center, the Detroit Free Press reports.

12 Jan 2010

Heart Disease News and Research

Latest Heart Disease News and Research

American Lung Association releases State of Tobacco Control 2009 report

American Heart Association encourages more Americans to get vaccinated against H1N1

Tocotrienol form of vitamin E prevents neural cell death and rescues the brain after stroke injury

Proteus Biomedical signs worldwide license and collaboration agreement with Novartis

National Salt Reduction Initiative unveils proposed targets to reduce salt levels in packaged and restaurant foods

University Hospitals in Cleveland selects Sectra as PACS provider

U-M Congenital Heart Center invites parents to submit queries on heart defect surgeries

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

American Heart Association supports salt reduction initiative

Isis Pharmaceuticals adds ISIS-APOCIIIRx to its development pipeline to treat TG

H1N1 flu vaccines and other resources for remaining healthy to be offered at Pennsylvania Farm Show

Yoga lowers number of compounds in blood and reduces inflammation

Paragon Biomedical launches second phase of restructuring and growth plan for worldwide operations

Experiments show Alzheimer's drug may halt the growth of oesophageal cancer

Second pivotal efficacy study not required for MAP Pharmaceuticals' LEVADEX NDA

ProPublica examines USAID efforts to fund, train local organizations in Pakistan

ARCA biopharma to receive US patent for methods of heart failure treatment with genetic testing based bucindolol

PDGFR's role in new blood vessel formation may explain cardiovascular side effects

Proteinuria, a long accepted indicator of heart disease risk, has less impact on African-Americans compared to whites

Detroit paper explores pain of facing breast cancer without insurance

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in